FFL
CPRX

Future Fund LLC’s Catalyst Pharmaceutical CPRX Stock Holding History

Future Fund LLC’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.35M Buy
94,727
+19,754
+26% +$471K 0.82% 52
2025
Q4 		$1.75M Buy
74,973
+28,433
+61% +$633K 0.55% 67
2025
Q3 		$917K Buy
46,540
+19,751
+74% +$406K 0.32% 130
2025
Q2 		$581K Buy
+26,789
New +$632K 0.26% 149

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Future Fund LLC's CPRX Position: Q1 2026 in Review

Future Fund LLC increased its Catalyst Pharmaceutical (CPRX) stake by 26% in Q1 2026, buying an estimated $471K and bringing the position to 94,727 shares worth $2.35M. The position accounts for 0.82% of the portfolio, ranked #52.

Future Fund LLC first reported a position in CPRX in Q2 2025 and has held it in 4 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Future Fund LLC held 94,727 shares of Catalyst Pharmaceutical worth $2.35M as of Q1 2026.
  • Future Fund LLC bought 19,754 Catalyst Pharmaceutical shares in Q1 2026, an estimated $471K.
  • Catalyst Pharmaceutical made up 0.82% of Future Fund LLC's portfolio in Q1 2026, its #52 holding.
  • Future Fund LLC first reported a position in Catalyst Pharmaceutical in Q2 2025 and has held it in 4 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Future Fund LLC's 13F filing for Q1 2026, filed 6 May 2026.